drugset / Trial / NCT07044141

Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

NCT07044141

Phase 1 Active not recruiting 20 enrolled Lahore General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

20 patients will be enrolled. All were given narrowband UVB . 10 wil be give oral azathriopfine . 10 will be given tofacitinib

Timeline

Start
2025-03-01
Primary completion
2025-09-30
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azathioprine Small molecule 50 mg
Comparator Tofacitinib Small molecule 5 mg Oral

Indications